Quick Answer
Serina Therapeutics, Inc. reported Shares Outstanding of 10.77 million shares for fiscal year 2025.
Serina Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 10.77M | +14.3% |
| 2024 | 9.42M | +12.0% |
| 2024 | 8.41M | +249.1% |
| 2023 | 2.41M | +123.4% |
| 2022 | 1.08M | -97.2% |
| 2021 | 37.94M | +0.7% |
| 2020 | 37.69M | +0.1% |
| 2019 | 37.65M | +5.1% |
| 2018 | 35.83M | +6.2% |
| 2017 | 33.75M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 10.54M | +18.6% | +3.9% |
| June 30, 2025 | 10.14M | +15.4% | +2.1% |
| March 31, 2025 | 9.93M | +18.0% | +5.4% |
| December 31, 2024 | 9.42M | +291.0% | +6.0% |
| September 30, 2024 | 8.89M | -76.6% | +1.1% |
| June 30, 2024 | 8.79M | -76.8% | +4.5% |
| March 31, 2024 | 8.41M | -77.8% | +249.1% |
| December 31, 2023 | 2.41M | -93.6% | -93.6% |
- Serina Therapeutics, Inc. showed an increase of +14.3% in Shares Outstanding compared to the prior fiscal year.
- Over the 2017–2025 period, Serina Therapeutics, Inc.’s shares outstanding has declined by 68.1% (from 33.75 million shares to 10.77 million shares).
- The most recent figure is from Serina Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: